A PILOT STUDY ON EFFICACY OF TADALAFIL IN BPH PATIENTS

Aadeesha A., Abhinand S., Keerthi Krishna R. R., Reshma Raj B. L. and Veena Vijayan G.*

ABSTRACT

Background: Benign prostatic hyperplasia (BPH) is the most common benign tumour in men and is responsible for urinary symptoms in the majority of males over the age of 50 years. Aim: Aim of this study is to assess the efficacy of Tadalafil 5mg OD in BPH patients. Objective: To assess the efficacy of Tadalafil in Benign Prostatic Hyperplasia patients. To describe the social and demographic clinical features of BPH patients. Materials and Method: The efficacy of Tadalafil will be assessed in 15 patients using International prostate symptom score questionnaire and the patients will be asked to review after one months of drug therapy. Results and Discussion: Tadalafil 5mg OD has significant effect on IPSS score(t = 11.64). Conclusion: Tadalafil 5mg OD is clinically significant in the improvement in LUTS secondary to BPH and there was an significant improvement in the IPSS score.

Keywords: Benign prostatic hyperplasia (BPH), Lower urinary tract symptoms(LUTS), Tadalafil.